Speaker illustration

Mr Aaram Omar Khader

ZAS, Antwerpen (Belgium)

Prevalence of reaching target low-density lipoprotein cholesterol (LDL-C) in very high-risk patients using high intensity lipid-modifying therapy.

Event: ESC Congress 2022

Topic: Prevention

Session: Predicting risks

Thumbnail